80 related articles for article (PubMed ID: 22703903)
1. Impact of diabetes on long-term mortality following multivessel percutaneous interventions: an insight into optimal statistical analysis.
Agarwal S; Bajaj NS; Zaman T; Banerjee S; Tuzcu EM; Ellis SG; Kapadia SR
Int J Cardiol; 2013 Sep; 167(5):2120-5. PubMed ID: 22703903
[TBL] [Abstract][Full Text] [Related]
2. In-hospital and 1-year outcomes with drug-eluting versus bare metal stents in saphenous vein graft intervention: a report from the EVENT registry.
Tolerico PH; Cohen DJ; Kleiman NS; Berger PB; Brilakis ES; Piana RN; Shammo S; Keyes MJ; Kennedy KF; Massaro JM; Saucedo JF;
Catheter Cardiovasc Interv; 2012 Dec; 80(7):1127-36. PubMed ID: 22431166
[TBL] [Abstract][Full Text] [Related]
3. Prognostic impact of using drug-eluting-stents on outcome and strategy in multivessel PCI: data from the Frankfurt MV-PCI registry.
Schwietz T; Ehrlich JR; De Rosa S; Fichtlscherer S; Schächinger V; Baier G; Laskowski R; Zeiher AM; Spyridopoulos I; Lehmann R
J Cardiol; 2013 Jan; 61(1):38-43. PubMed ID: 23084576
[TBL] [Abstract][Full Text] [Related]
4. Long-term effects of drug-eluting stents versus bare metal stents on patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: outcomes of 3-year clinical follow-up.
Wang CH; Fang Q; Zhang SY; Shen ZJ; Fan ZJ; Jin XF; Zeng Y; Liu ZY; Xie HZ; Yang M
Chin Med J (Engl); 2012 Aug; 125(16):2803-6. PubMed ID: 22932070
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis comparing efficacy and safety of first generation drug-eluting stents to bare-metal stents in patients with diabetes mellitus undergoing primary percutaneous coronary intervention.
De Luca G; Dirksen MT; Spaulding C; Kelbæk H; Schalij M; Thuesen L; van der Hoeven B; Vink MA; Kaiser C; Musto C; Chechi T; Spaziani G; Diaz de la Llera LS; Pasceri V; Di Lorenzo E; Violini R; Suryapranata H; Stone GW;
Am J Cardiol; 2013 May; 111(9):1295-304. PubMed ID: 23490029
[TBL] [Abstract][Full Text] [Related]
6. Early beneficial effects of drug-eluting stents in vein grafts wane during long term follow-up: a case-control study.
Pasceri V; Tarsia G; Niccoli G; Viceconte N; Porto I; Leone AM; Trani C; Speciale G; Lisanti P
Catheter Cardiovasc Interv; 2012 Dec; 80(7):1112-7. PubMed ID: 22422701
[TBL] [Abstract][Full Text] [Related]
7. Long-term predictors of mortality after percutaneous coronary intervention in the era of drug-eluting stents.
Wilson WM; Andrianopoulos N; Clark D; Duffy SJ; Brennan A; Harries I; New G; Sebastian M; Loane P; Reid C; Ajani AE
Am J Cardiol; 2011 Oct; 108(7):936-42. PubMed ID: 21920184
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcomes of older diabetic patients after percutaneous coronary stenting in the United States: a report from the National Cardiovascular Data Registry, 2004 to 2008.
Hillegass WB; Patel MR; Klein LW; Gurm HS; Brennan JM; Anstrom KJ; Dai D; Eisenstein EL; Peterson ED; Messenger JC; Douglas PS
J Am Coll Cardiol; 2012 Dec; 60(22):2280-9. PubMed ID: 23194940
[TBL] [Abstract][Full Text] [Related]
9. Drug-eluting or bare-metal stenting in patients with diabetes mellitus: results from the Massachusetts Data Analysis Center Registry.
Garg P; Normand SL; Silbaugh TS; Wolf RE; Zelevinsky K; Lovett A; Varma MR; Zhou Z; Mauri L
Circulation; 2008 Nov; 118(22):2277-85, 7p following 2285. PubMed ID: 19001019
[TBL] [Abstract][Full Text] [Related]
10. Long-term safety and effectiveness of drug-eluting stents compared to bare metal stents following successful PCI in non-ST-elevation myocardial infarction: findings from the Guthrie Health Off-Label StenT (GHOST) Registry.
Harjai KJ; Sattur S; Orshaw P; Boura J
J Interv Cardiol; 2012 Feb; 25(1):28-36. PubMed ID: 21981467
[TBL] [Abstract][Full Text] [Related]
11. First and second generation DESs reduce diabetes adverse effect on mortality and re-intervention in multivessel coronary disease: 9-Year analysis.
Badour SA; Dimitrova KR; Kanei Y; Tranbaugh RF; Hajjar MM; Kabour A; Schwann TA; Alam S; Badr K; Habib RH
Cardiovasc Revasc Med; 2017 Jun; 18(4):265-273. PubMed ID: 28314676
[TBL] [Abstract][Full Text] [Related]
12. One-year outcome of patients with diabetes mellitus after percutaneous coronary intervention with three different revascularization strategies: results from the Diabetic Argentina Registry (DEAR).
Mieres J; Fernandez-Pereira C; Risau G; Solorzano L; Pauletto R; Rodriguez-Granillo AM; Rubilar B; Stella P; Rodriguez AE
Cardiovasc Revasc Med; 2012; 13(5):265-71. PubMed ID: 22796496
[TBL] [Abstract][Full Text] [Related]
13. Four-year clinical outcome of sirolimus- and paclitaxel-eluting stents compared to bare-metal stents for the percutaneous treatment of stable coronary artery disease.
Simsek C; Onuma Y; Magro M; de Boer S; Battes L; van Domburg RT; Boersma E; Serruys PW;
Catheter Cardiovasc Interv; 2010 Jul; 76(1):41-9. PubMed ID: 20310019
[TBL] [Abstract][Full Text] [Related]
14. Comparison of long-term outcomes in STEMI and NSTE-ACS after coronary stent placement: an analysis in a real world BMS and DES population.
van Leeuwen MA; Daemen J; van Mieghem NM; de Boer SP; Boersma E; van Geuns RJ; Zijlstra F; van Domburg RT; Serruys PW;
Int J Cardiol; 2013 Sep; 167(5):2082-7. PubMed ID: 22664371
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcomes after stenting versus coronary artery bypass grafting for unprotected left main coronary artery disease: 10-year results of bare-metal stents and 5-year results of drug-eluting stents from the ASAN-MAIN (ASAN Medical Center-Left MAIN Revascularization) Registry.
Park DW; Kim YH; Yun SC; Lee JY; Kim WJ; Kang SJ; Lee SW; Lee CW; Kim JJ; Choo SJ; Chung CH; Lee JW; Park SW; Park SJ
J Am Coll Cardiol; 2010 Oct; 56(17):1366-75. PubMed ID: 20946993
[TBL] [Abstract][Full Text] [Related]
16. Long-term clinical outcomes and cost-effectiveness analysis in multivessel percutaneous coronary interventions: comparison of drug-eluting stents, bare-metal stents and a mixed approach in patients at high and low risk of repeat revascularisation.
Varani E; Guastaroba P; Di Tanna GL; Saia F; Balducelli M; Campo G; Vignali L; Rossi R; Manari A; Piovaccari G; De Palma R; Marzocchi A
EuroIntervention; 2010 Apr; 5(8):953-61. PubMed ID: 20542781
[TBL] [Abstract][Full Text] [Related]
17. Long-term clinical benefit of drug-eluting stents over bare-metal stents in diabetic patients with de novo left main coronary artery disease: results from a real-world multicenter registry.
Capodanno D; Di Salvo ME; Palmerini T; Sheiban I; Margheri M; Vecchi G; Sangiorgi G; Piovaccari G; Bartorelli A; Briguori C; Ardissino D; Di Pede F; Ramondo A; Inglese L; Petronio AS; Bolognese L; Benassi A; Palmieri C; Filippone V; De Servi S; Tamburino C
Catheter Cardiovasc Interv; 2009 Feb; 73(3):310-6. PubMed ID: 19214964
[TBL] [Abstract][Full Text] [Related]
18. Short and long term outcome of percutaneous coronary intervention with drug eluting stent and bare metal stent in patients with chronic kidney disease.
Resmini C; Di Cuia M; Ballocca F; D'Ascenzo F; Bollati M; Moretti C; Omedè PL; Sciuto F; Gaita F; Sheiban I
Minerva Cardioangiol; 2012 Dec; 60(6):573-80. PubMed ID: 23147435
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcome after surgical or percutaneous revascularization in coronary bypass graft failure.
Harskamp RE; Beijk MA; Damman P; Kuijt WJ; Woudstra P; Grundeken MJ; Kloek JJ; Tijssen JG; de Mol BA; de Winter RJ
J Cardiovasc Med (Hagerstown); 2013 Jun; 14(6):438-45. PubMed ID: 22828774
[TBL] [Abstract][Full Text] [Related]
20. Effect of race and ethnicity on outcomes with drug-eluting and bare metal stents: results in 423 965 patients in the linked National Cardiovascular Data Registry and centers for Medicare & Medicaid services payer databases.
Kumar RS; Douglas PS; Peterson ED; Anstrom KJ; Dai D; Brennan JM; Hui PY; Booth ME; Messenger JC; Shaw RE
Circulation; 2013 Apr; 127(13):1395-403. PubMed ID: 23547179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]